Skip to content

Reviva Pharmaceuticals Holdings, Inc.

RVPH

CIK 0001742927

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$19.69M
+33.6% YoY Q1 May 2026
EPS Diluted (TTM)
—
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$22.19M
Q1 May 2026
Total Debt
$231.27K
Q1 May 2026
Shares Outstanding
13.11M sh
Q1 May 2026

Revenue & Net Income

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings